Department of Radiology

Publications

2017

Thiele NA, Brown V, Kelly JM, Amor-Coarasa A, Jermilova U, MacMillan SN, et al. An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy. Angew Chem Int Ed Engl. 2017;56(46):14712-14717.

Soman S, Bregni JA, Bilgic B, Nemec U, Fan A, Liu Z, et al. Susceptibility-Based Neuroimaging: Standard Methods, Clinical Applications, and Future Directions. Curr Radiol Rep. 2017;5(3).

Zhang J, Winters K, Reynaud O, Kim SG. Simultaneous measurement of T /B and pharmacokinetic model parameters using active contrast encoding (ACE)-MRI. NMR Biomed. 2017;30(9).

Kim H-, Park S, Rhee HY, Lee KM, Ryu C-, Rhee SJ, et al. Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease. Neuroimage Clin. 2017;16:429-438.

Cheal SM, Fung EK, Patel M, Xu H, Guo H-, Zanzonico PB, et al. Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer. J Nucl Med. 2017;58(11):1735-1742.

Winkler SA, Picot PA, Thornton MM, Rutt BK. Direct SAR mapping by thermoacoustic imaging: A feasibility study. Magn Reson Med. 2017;78(4):1599-1606.

Tung C-, Han MS, Kim Y, Qi J, O'Neill BE. Tumor ablation using low-intensity ultrasound and sound excitable drug. J Control Release. 2017;258:67-72.

Li L, Ding S, Yang Y, Zhu A, Fan X, Cui M, et al. Multicomponent Aqueous Synthesis of Iodo-1,2,3-triazoles: Single-Step Models for Dual Modification of Free Peptide and Radioactive Iodo Labeling. Chemistry. 2017;23(5):1166-1172.

Zun Z, Zaharchuk G, Andescavage NN, Donofrio MT, Limperopoulos C. Non-Invasive Placental Perfusion Imaging in Pregnancies Complicated by Fetal Heart Disease Using Velocity-Selective Arterial Spin Labeled MRI. Sci Rep. 2017;7(1):16126.

Eich TS, Razlighi QR, Stern Y. Perceptual and memory inhibition deficits in clinically healthy older adults are associated with region-specific, doubly dissociable patterns of cortical thinning. Behav Neurosci. 2017;131(3):220-225.